HR. 1082In Committee
Shandra Eisenga Human Cell and Tissue Product Safety Act
Establishes civil penalties and FDA reporting and education requirements for human cell and tissue product safety oversight
Plain-English overview
What this bill does
Establishes civil penalties and FDA reporting and education requirements for human cell and tissue product safety oversight
Key points
- Establish civil penalties
- Require FDA reports
- Require educational materials
- Direct FDA workshops
Current status
Where it stands
Status
In Committee
Latest action
2025-06-24 — Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedAdministrative law and regulatory proceduresCivil actions and liabilityCongressional oversightDepartment of Health and Human ServicesHealthHealth programs administration and fundingHealth promotion and preventive care